Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,230
Employees2,230
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,230
Employees2,230

ALNY Key Statistics

Market cap
57.06B
Market cap57.06B
Price-Earnings ratio
-176.37
Price-Earnings ratio-176.37
Dividend yield
—
Dividend yield—
Average volume
1.54M
Average volume1.54M
High today
$436.77
High today$436.77
Low today
$425.94
Low today$425.94
Open price
$430.00
Open price$430.00
Volume
1.15M
Volume1.15M
52 Week high
$436.77
52 Week high$436.77
52 Week low
$205.87
52 Week low$205.87

Analyst ratings

76%

of 34 ratings
Buy
76.5%
Hold
20.6%
Sell
2.9%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.
Eli Lilly
Vertex Pharmaceuticals
Netflix
CrowdStrike Holdings
Taiwan Semiconductor Manu…
Meta Platforms
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.